课题基金 / 基金详情

Mechanism for MHC class II E region-linked autoimmune suppression.

Mechanism for MHC class II E region-linked autoimmune suppression.
MHC II 类 E 区相关自身免疫抑制的机制。
批准号:
12670309
负责人:
HIROSE Sachiko
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

HIROSE Sachiko的其他基金

相似基金

相关文献

中文摘要
翻译
(NZB x NZW) F1小鼠自发发生类似人类系统性红斑狼疮的自身免疫性疾病。主要组织相容性复合体(MHG)的H-2^<d/z>杂合性限制了疾病的发生,NZB株的H-2^<d>和NZW株的H-2^< z>。对自身反应性T细胞克隆的研究表明,Aα^<d> Aβ^<z>分子可能是疾病加速的候选分子。在本研究中,我们建立了h -2基因的NZB。GD和NZW。GD菌株携带H-2^<g2>单倍型,由于发生在Ea亚区左侧的交叉,H-2^d和H-2^b单倍型之间存在H-2内重组。因为Ea^b是一个空等位基因,这些同源菌株不表达E分子。(NZB x NZW. h -2^d) Fl、(NZB x NZW. h) Fl的疾病严重程度比较。GD) F1和(NZB)。GD x NZW。GD) Fl小鼠的疾病严重程度受Ea连锁亚区控制,Ea^d抑制疾病。此外,(NZB x NZW)的疾病严重程度。与未处理的(NZB x NZW)相比,从(NZB x NZW) F1小鼠转移CD^<8+> T细胞的GD) F1小鼠明显受到抑制。GD) F1小鼠。为了确定疾病抑制的确切亚区,我们在Ea亚区右侧建立了新的H-2重组基因菌株,携带H-2^<d>和H-2^<b>单倍型之间的H-2重组。CD8^+ T细胞抑制疾病的机制正在研究中。
英文摘要
The (NZB x NZW) F1 mice spontaneously develop autoimmune disease resembling human systemic lupus erythematosus. The occurrence of disease is restricted by H-2^<d/z> heterozygosity of the major histocompatibility complex (MHG), H-2^<d> from NZB and H-2^<Z> of NZW strains. Studies on autoreactive T cell clones suggest that Aα^<d> Aβ^<z> molecules may be candidate for disease acceleration. In the present studies, we established H-2-congenic NZB.GD and NZW.GD strains carrying H-2^<g2> haplotype, showing the intra-H-2 recombination between H-2^d and H-2^b haplotype, as a result of crossing-over which occurred to the left of the Ea subregion. Because Ea^b is a null allele, these congenic strains do not express E molecules. Comparison of disease severity among (NZB x NZW.H-2^d) Fl, (NZB x NZW.GD) F1 and (NZB.GD x NZW.GD) Fl mice showed that disease severity is controlled by Ea-linked subregion and that Ea^d suppress the disease. Furthermore, the disease severity in (NZB x NZW. GD) F1 mice transferred with CD^<8+> T cells from (NZB x NZW.H-2^<d>) F1 mice was markedly suppressed, as compared with non-treated (NZB x NZW.GD) F1 mice. To identify exact subregion for disease suppression, we have been establishing new H-2 recombinant-congenic strains carrying intra-H-2 recombination between H-2^<d> and H-2^<b> haplotype to the right of Ea subregion. The mechanism for disease suppression by CD8^+ T cells is under investigation.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
Hirose, S.et al.: "Genetic aspects of inherent B-cell abnormalities associated with SLE and B-cell malignancy : Lessons from New Zealand mouse models."Int Rev. Immunol.. 19. 389-421 (2000)
Hirose, S.等人:“与 SLE 和 B 细胞恶性肿瘤相关的固有 B 细胞异常的遗传方面:来自新西兰小鼠模型的教训。”Int Rev.Immunol.. 19. 389-421 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条
    Epistatic interaction of FcgammaRIIB and Sle16 polymorphism in rheumatoid arthritis
    • 批准号:
      24590491
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2012
    • 负责人:
      HIROSE Sachiko
    • 依托单位:
    A novel regulatory role of IgG Fc receptor IIB in Flt3L-mediated dendritic cell development
    • 批准号:
      19591181
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2007
    • 负责人:
      HIROSE Sachiko
    • 依托单位:
    Role of G-CSF and C-CSF receptor gene polymorphisms for the development of lupus nephritis
    • 批准号:
      15300145
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.59万
    • 财政年份:
      2003
    • 负责人:
      HIROSE Sachiko
    • 依托单位:
    Ltk gene polymorphism and aberrant activation of autoreactive B cells
    • 批准号:
      14380385
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.34万
    • 财政年份:
      2002
    • 负责人:
      HIROSE Sachiko
    • 依托单位:
    海外基金